ÂÜÀòÂÒÂ×

Robin Eryan, MS, MBA, currently serves as a Senior Clinical Scientist at Valerio Therapeutics, where responsibilities include providing scientific and medical support for Phase I/II Solid Tumor Basket Studies and a Private Partner Immuno-Oncology Biologics License Application filing. Prior experience includes a role as Clinical Scientist at Parexel, supporting a Phase II NSCLC Umbrella Program, and as Clinical Research Monitor at Moffitt Cancer Center, focusing on metrics and efficiencies for oncology trials. Additional consulting roles were held in Tampa from 2012 to 2019, providing scientific support and oversight for pediatric and adult hematology trials. Robin Eryan also took a professional career break from 2001 to 2006 as an expatriate in France, following a history of multiple full-time positions in large pharmaceutical companies. Educational qualifications include a Master’s Degree in Biology from Seton Hall University and an MBA in Marketing and International Business from Rutgers Business School.